| Literature DB >> 19516893 |
Claudia Auw-Haedrich1, Gottfried Martin, Helga Spelsberg, Rainer Sundmacher, Nikolaus Freudenberg, Philip Maier, Thomas Reinhard.
Abstract
The aim of our study was to identify the frequency of expression of p16(INK4a) (CDKN2A) and HPV (human papilloma virus) in different grades of conjunctival intraepithelial neoplasia (CIN).Twelve specimens including CIN I (2), II (3), III (5), and CIN with beginning invasion (2), as well as 15 control specimens, were stained with antibodies against p16(INK4a) and MIB1. The presence of HPV was examined by PCR.p16 as well as MIB1 were significantly elevated in CIN compared to control specimens (p<0.01) without correlation with the differentiation grade. Only two cases with CIN grade 3 contained HPV 16.As few control specimens also showed increased p16(INK4a) expression, p16(INK4a) seems not to be a very reliable marker for the exact determination of CIN. It could serve as an additional diagnostic tool besides the morphological characterization. Our study suggested that p16(INK4a) elevation is not associated with HPV infection.Entities:
Keywords: HPV.; conjunctival intraepithelial neoplasia; p16
Year: 2008 PMID: 19516893 PMCID: PMC2687927 DOI: 10.2174/1874364100802010048
Source DB: PubMed Journal: Open Ophthalmol J ISSN: 1874-3641
Clinical Data of the CIN Specimens
| No | Age | Gender | Clinical Findings | Treatment Prior to Excision | Risk Factors | Proposed Pathogenic Sequence | Tumor Location |
|---|---|---|---|---|---|---|---|
| 1 | 79 | f | Chronic conjunctivitis | Cromoglycic acid | None | Primary CIN? | Limbus, 16x6x4mm |
| 2 | 67 | m | Conjunctivitis | None | None | Primary CIN? | Nasal and temporal limbus |
| 3 | 39 | m | Red eye | Vit A ointment | None | Primary CIN? | Temporal limbus |
| 4 | 73 | m | Corneal neoplasia | None | None | Possibly primary CIN developing from a pinguecula | Corneal at the limbus, adjacent to pinguecula |
| 5 | 61 | m | Corneal neoplasia | None | None | Primary CIN? | Medial limbus with corneal part (2-3mm) 10x5x2mm |
| 6 | 64 | m | At least 4 years ocular surface problems with circular pannus | Topical steroids, antiviral ointment | HPV 16 | Malignant transformation due to HPV 16 | Limbus with corneal part at 7 and 12h |
| 7 | 67 | m | "Pterygium" since at least 3 years with unusual extension | None | None | Primary CIN mimicking pterygium or CIN developing from altered epithelium of a pterygium | Medial limbus with corneal part (2mm) |
| 8 | 56 | f | Atypical Pterygium with whitish plaque and vascularisation | None | HPV 16 | Malignant transformation due to HPV 16 | Limbus, 11x7x1mm |
| 9 | 61 | m | Red eye | None | None | Primary CIN? | Medial limbus with corneal part (2mm) |
| 10 | 53 | m | Superficial vascularisation onto the cornea | None | Explosion injury 30 years previously | DNA-damage due to the trauma and malignant transformation during repair phase | Limbus with corneal part (2mm) |
| 11 | 29 | m | Whitish neoplasia | 1991 tectonic keratoplasty due to malignancy, 1992 rekeratoplasty due to corneal melting | Xeroderma pigmentosum, UV-B radiation | DNA-damage and malignant transformation due to UV-B radiation and defective repair mechanisms | Limbus with corneal part (4mm) 4x4x2 |
| 12 | 67 | m | Red eye | Dexpanthenol eye drops | None | Primary CIN? | Medial limbus |
Normal Bulbar Conjunctival Specimens and the Proportion of p16 and MIB-1 Positive Cells
| No | p16-Positive Cells | MIB-1-Positive Cells | HPV | β-Actin | Postmortem Time h=hours, ‘=min |
|---|---|---|---|---|---|
| 1 | 6.8% (37/545) | 0% (1/500) | - | + | 23h 40' |
| 2 | 0.1% (1/751) | 0% (0/500) | - | + | <24h |
| 3 | 29.0% (228/785) | 0% (0/500) | - | + | 26h 10' |
| 4 | 0.0% (0/750) | 0% (0/500) | - | + | 23h 21' |
| 5 | 27.3% (241/883) | 0% (0/500) | - | + | 20h 30' |
| 6 | 0.0% (0/750) | 0% (0/500) | - | + | 22h |
| 7 | 0.0% (0/750) | 0% (0/500) | - | + | 21h 3' |
| 8 | 51.8% (309/597) | 0% (1/500) | - | + | 21h 48' |
| 9 | 0.0% (0/500) | 0% (0/500) | - | - | <24h |
| 10 | 0,0 (0/500) | 0% (0/500 | - | + | 10h |
| 11 | 22.5% (120/534) | 0% (1/500) | - | + | 15h 5’ |
| 12 | 72.1% (382/530) | 0% (0/500) | - | + | 20h 20’ |
| 13 | 12.4% (71/571) | n.a. | - | + | 0h (biopsy) |
| 14 | 0.6% (3/503) | n.a. | - | + | 15h 30’ |
| 15 | 23.8% (121/509) | n.a. | - | + | 24 h |
| Mean ± SD | 16.43 ± 21.87 | 0.033 ± 0.078 | 18.2 ± 7.1 |
Differentiation Grade of the CIN Specimens and the Proportion of p16 and MIB-1 Positive Cells (Grade 4 = CIN with Beginning Invasion)
| No. | Grade | p16-Positive Cells | MIB-1-Positive Cells | HPV | β-Actin |
|---|---|---|---|---|---|
| 1 | 1 | 66% (402/614) | 3% (15/510) | - | + |
| 2 | 1 | 51% (263/521) | 4% (22/522) | - | + |
| 3 | 2 | 57% (312/550) | 13% (72/552) | - | + |
| 4 | 2 | 46% (258/558) | 16% (89/569) | - | + |
| 5 | 2 | 41% (320/782) | 10% (72/694) | - | + |
| 6 | 3 | 53% (378/720) | 16% (120/754) | + (type 16) | + |
| 7 | 3 | 41% (251/615) | 8% (70/831) | - | + |
| 8 | 3 | 84% (536/639) | 18% (118/649) | + (type 16) | + |
| 9 | 3 | 59% (395/669) | 30% (183/613) | - | + |
| 10 | 3 | 83% (598/725) | 12% (60/502) | - | + |
| 11 | 4 | 27% (149/547) | 3% (15/539) | - | n.a. |
| 12 | 4 | 37% (247/664) | 8% (42/546) | - | + |
| Mean ± SD | 53.6 ± 17.3 | 12% ± 8% |